262 related articles for article (PubMed ID: 15694126)
21. Long-range activation of Sox9 in Odd Sex (Ods) mice.
Qin Y; Kong LK; Poirier C; Truong C; Overbeek PA; Bishop CE
Hum Mol Genet; 2004 Jun; 13(12):1213-8. PubMed ID: 15115764
[TBL] [Abstract][Full Text] [Related]
22. Parallel expression of Sox9 and Col2a1 in cells undergoing chondrogenesis.
Zhao Q; Eberspaecher H; Lefebvre V; De Crombrugghe B
Dev Dyn; 1997 Aug; 209(4):377-86. PubMed ID: 9264261
[TBL] [Abstract][Full Text] [Related]
23. SOX9 exerts a bifunctional effect on type II collagen gene (COL2A1) expression in chondrocytes depending on the differentiation state.
Kypriotou M; Fossard-Demoor M; Chadjichristos C; Ghayor C; de Crombrugghe B; Pujol JP; Galéra P
DNA Cell Biol; 2003 Feb; 22(2):119-29. PubMed ID: 12713737
[TBL] [Abstract][Full Text] [Related]
24. The transcription factor Znf219 regulates chondrocyte differentiation by assembling a transcription factory with Sox9.
Takigawa Y; Hata K; Muramatsu S; Amano K; Ono K; Wakabayashi M; Matsuda A; Takada K; Nishimura R; Yoneda T
J Cell Sci; 2010 Nov; 123(Pt 21):3780-8. PubMed ID: 20940257
[TBL] [Abstract][Full Text] [Related]
25. Loss of Sox9 function results in defective chondrocyte differentiation of mouse embryonic stem cells in vitro.
Hargus G; Kist R; Kramer J; Gerstel D; Neitz A; Scherer G; Rohwedel J
Int J Dev Biol; 2008; 52(4):323-32. PubMed ID: 18415932
[TBL] [Abstract][Full Text] [Related]
26. Igf-I extends the chondrogenic potential of human articular chondrocytes in vitro: molecular association between Sox9 and Erk1/2.
Shakibaei M; Seifarth C; John T; Rahmanzadeh M; Mobasheri A
Biochem Pharmacol; 2006 Nov; 72(11):1382-95. PubMed ID: 17010943
[TBL] [Abstract][Full Text] [Related]
27. In vivo human Cartilage oligomeric matrix protein (COMP) promoter activity.
Posey KL; Davies S; Bales ES; Haynes R; Sandell LJ; Hecht JT
Matrix Biol; 2005 Dec; 24(8):539-49. PubMed ID: 16214313
[TBL] [Abstract][Full Text] [Related]
28. Sphingomyelinase decreases type II collagen expression in bovine articular cartilage chondrocytes via the ERK signaling pathway.
Gilbert SJ; Blain EJ; Duance VC; Mason DJ
Arthritis Rheum; 2008 Jan; 58(1):209-20. PubMed ID: 18163502
[TBL] [Abstract][Full Text] [Related]
29. Disease- and cell-type-specific transcriptional targeting of vectors for osteoarthritis gene therapy: further development of a clinical canine model.
Campbell SE; Bennett D; Nasir L; Gault EA; Argyle DJ
Rheumatology (Oxford); 2005 Jun; 44(6):735-43. PubMed ID: 15757961
[TBL] [Abstract][Full Text] [Related]
30. Ubiquitin-proteasome degradation of KLF5 transcription factor in cancer and untransformed epithelial cells.
Chen C; Sun X; Ran Q; Wilkinson KD; Murphy TJ; Simons JW; Dong JT
Oncogene; 2005 May; 24(20):3319-27. PubMed ID: 15735697
[TBL] [Abstract][Full Text] [Related]
31. Ubiquitin-proteasome system impairment caused by a missense cardiac myosin-binding protein C mutation and associated with cardiac dysfunction in hypertrophic cardiomyopathy.
Bahrudin U; Morisaki H; Morisaki T; Ninomiya H; Higaki K; Nanba E; Igawa O; Takashima S; Mizuta E; Miake J; Yamamoto Y; Shirayoshi Y; Kitakaze M; Carrier L; Hisatome I
J Mol Biol; 2008 Dec; 384(4):896-907. PubMed ID: 18929575
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of SOX9 in mouse embryonic stem cells directs the immediate chondrogenic commitment.
Kim JH; Do HJ; Yang HM; Oh JH; Choi SJ; Kim DK; Cha KY; Chung HM
Exp Mol Med; 2005 Aug; 37(4):261-8. PubMed ID: 16155402
[TBL] [Abstract][Full Text] [Related]
33. Restoration of the extracellular matrix in human osteoarthritic articular cartilage by overexpression of the transcription factor SOX9.
Cucchiarini M; Thurn T; Weimer A; Kohn D; Terwilliger EF; Madry H
Arthritis Rheum; 2007 Jan; 56(1):158-67. PubMed ID: 17195218
[TBL] [Abstract][Full Text] [Related]
34. Amyloid peptide attenuates the proteasome activity in neuronal cells.
Oh S; Hong HS; Hwang E; Sim HJ; Lee W; Shin SJ; Mook-Jung I
Mech Ageing Dev; 2005 Dec; 126(12):1292-9. PubMed ID: 16153690
[TBL] [Abstract][Full Text] [Related]
35. Sox9-dependent transcriptional regulation of the proprotein convertase furin.
Guimont P; Grondin F; Dubois CM
Am J Physiol Cell Physiol; 2007 Jul; 293(1):C172-83. PubMed ID: 17360815
[TBL] [Abstract][Full Text] [Related]
36. [Sox family regulate chondrogenesis].
Akiyama H
Clin Calcium; 2006 Feb; 16(2):368- 72. PubMed ID: 16465043
[TBL] [Abstract][Full Text] [Related]
37. Destabilization of Krüppel-like factor 4 protein in response to serum stimulation involves the ubiquitin-proteasome pathway.
Chen ZY; Wang X; Zhou Y; Offner G; Tseng CC
Cancer Res; 2005 Nov; 65(22):10394-400. PubMed ID: 16288030
[TBL] [Abstract][Full Text] [Related]
38. Bcl-2-associated athanogene-1 (BAG-1): a transcriptional regulator mediating chondrocyte survival and differentiation during endochondral ossification.
Tare RS; Townsend PA; Packham GK; Inglis S; Oreffo RO
Bone; 2008 Jan; 42(1):113-28. PubMed ID: 17950682
[TBL] [Abstract][Full Text] [Related]
39. Phosphorylation of SOX9 by cyclic AMP-dependent protein kinase A enhances SOX9's ability to transactivate a Col2a1 chondrocyte-specific enhancer.
Huang W; Zhou X; Lefebvre V; de Crombrugghe B
Mol Cell Biol; 2000 Jun; 20(11):4149-58. PubMed ID: 10805756
[TBL] [Abstract][Full Text] [Related]
40. Adjacent DNA sequences modulate Sox9 transcriptional activation at paired Sox sites in three chondrocyte-specific enhancer elements.
Bridgewater LC; Walker MD; Miller GC; Ellison TA; Holsinger LD; Potter JL; Jackson TL; Chen RK; Winkel VL; Zhang Z; McKinney S; de Crombrugghe B
Nucleic Acids Res; 2003 Mar; 31(5):1541-53. PubMed ID: 12595563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
